DISHMAN CARBOGEN AMCIS
Back to Cashflow Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-102 Cr | ₹-22 Cr | ₹250 Cr | ₹130 Cr | ₹-11 Cr |
What is the latest Cash Flow from Financing Activities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-102 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹-11 Cr |
How is Cash Flow from Financing Activities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-102 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹250 Cr | 91.52 | |
| Mar2022 | ₹130 Cr | Positive | |
| Mar2021 | ₹-11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,672.7 Cr | 1.9% | -1% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 1.9% |
-1% |
-38.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses